tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Francois Brisebois, 86 are a BUY (92.47%), 7 are a HOLD (7.53%).
Analyst Francois Brisebois works at OPPENHEIMER with a stock forecast success ratio of 21.8% fulfilled within 110.3 days on average.
Francois Brisebois’s has documented 174 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KALA, Kala Pharmaceuticals at 02-Apr-2024.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for DMTK (DERMTECH) at 1/22/2021. The price target of $53 was fulfilled within 14 days with a profit of $10.08 (23.49%) receiving and performance score of 16.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
27
$9.7 (56.07%)
25
3 months 15 days ago
6/13 (46.15%)
$11.37 (72.74%)
440
Buy
20
$2.7 (15.61%)
19
4 months 4 days ago
20/22 (90.91%)
$6.44 (47.49%)
319
Buy
21
$3.7 (21.39%)
21
8 months 14 days ago
4/6 (66.67%)
$7.57 (56.37%)
380
Buy
18
$0.7 (4.05%)
18
8 months 14 days ago
4/4 (100%)
$4.57 (34.03%)
1060
Buy
18
$4.69 (35.24%)
16
9 months 25 days ago
2/4 (50%)
$1.52 (9.22%)
169
Which stock is Francois Brisebois is most bullish on?
Which stock is Francois Brisebois is most reserved on?
What Year was the first public recommendation made by Francois Brisebois?
